Abstract:Introduction: Dendritic cells (DCs) have long been thought to function as passenger leukocytes that instigate the host anti-allograft response. However, there is cumulative evidence that DCs are not only stimulators of T cells but also play crucial roles in central and peripheral tolerance. Recently, the processing and presentation of antigens by different types of DCs have been appreciated as the initial events involved in determining immune responses. When exposed to inflammatory conditions, tolerogenic DCs, which have an immature phenotype, inhibit T cell responses and favor regulatory T cell induction/expansion. Methods: Human immune systerm has been reconstructed in NOD/SCID mouse by transplanting fetal human thymus, liver tissue and CD34+ cells. Before allo skin transplantation in humanized NOD/SCID mouse, the ILT3high DCs had been injected. After the skin transplantation from the 5th day, the survival time and morphological changes of the trasplanted grafts were observed. On the 7th day, the rejection degrees of skin grafts observed with HE staining were classified. In vivo, the change of T cell-subsets in peripheral blood was detected by flow cytometry, and ELISA was used to determine the dynamic changes of serum cytokines IL-2 and IL-10 of the recipients after transplantation. Results: After reconstruction of human immune systerm in NOD/SCID mouse, human CD4+ and CD8+ T cells were detected in peripheral blood, and the level increased until 16w˜20w. Allogeneic skin grafts could survive only 9-14d, because of rejectation. In the skin transplantation model, the ILT3high DCs group could better suppress rejction and prolong allogeneic skin graft survival time, reduce graft pathological damage. 7 days after skin transplantation, one-way MLR was used to detect donors and recipients in each group and found that the reactivity of the re-stimulation of ILT3high DCs group was significantly lower than that in other groups (P < 0.05). In vivo, ILT3high DCs could inhibit the secretion of IL-2, and promoted the the secretion of IL-10. And the Tregs level of ILT3high DCs group was significantly higher (p< 0.05vs control group) in peripheral blood, which was consistent with the results of quantitative analysis of Foxp3 mRNA with RT-PCR. Conclusions: This Atifical ILT3high DCs could significantly inhibited the lymphocyte proliferation, activation, and lymphocyte reactivity of the recipient in vivo, and significantly prolong the survival time of skin graft, and reduce the pathological of rejectional damage.

The Amelioration of Composite Tissue Allograft Rejection by TIM-3-modified Dendritic Cell: Regulation of the Balance of Regulatory and Effector T Cells.

Efficacy of Ctla4-Ig in Preventing Acute Rejection of Fully Allogeneic Heart Allografts in Sensitized Recipients

Fragile TIM-4-expressing Tissue Resident Macrophages Are Migratory and Immunoregulatory

Gut Microbes Enlarged the Protective Effect of Transplanted Regulatory B Cells on Rejection of Cardiac Allografts.

Helper T Cell (CD4 + ) Targeted Tacrolimus Delivery Mediates Precise Suppression of Allogeneic Humoral Immunity

Deletion of Smad3 Improves Cardiac Allograft Rejection in Mice.

Inactivation Of T-Cell Receptor-Mediated Integrin Activation Prolongs Allograft Survival In Amap-Deficient Mice

Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.

Combination of C-X-C motif chemokine 9 and C-X-C motif chemokine 10 antibodies with FTY720 prolongs the survival of cardiac retransplantation allografts in a mouse model

TGF-beta(1) gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo.

METTL3 inhibition reduces N6 -methyladenosine levels and prevents allogeneic CD4+ T-cell responses

T Cell CEACAM1-TIM-3 Crosstalk Alleviates Liver Transplant Injury in Mice and Humans

Tim-1 Blockade with RMT1-10 Increases T Regulatory Cells and Prolongs the Survival of High-Risk Corneal Allografts in Mice.

In Vivo Attenuation of Antibody-Mediated Acute Renal Allograft Rejection by Ex Vivo TGF-β-Induced CD4+Foxp3+ Regulatory T Cells

Graft Protective and Intercellular Immunomodulatory Effects by Adoptive Transfer of an Agonistic Anti-BTLA mAb (3C10) Induced CD4+CD25+ Regulatory T Cells in Murine Cardiac Allograft Transplant Model

An Agonistic Anti-BTLA mAb (3C10) Induced Generation of IL-10-Dependent Regulatory CD4+ T Cells and Prolongation of Murine Cardiac Allograft

Intragraft regulatory T cells in the modern era: what can high-dimensional methods tell us about pathways to allograft acceptance?

Prolonged Survival of Skin Graft by Dendritic Cells Derived Donor-Specific Ilt3 Lentivirus-Transduced Human Cd34(+) Cells in Hu-Nod/Scid Mice

Cutting Edge: Membrane Lymphotoxin Regulates Cd8(+) T Cell-Mediated Intestinal Allograft Rejection

Transfer of Regulatory T Cells Generated Ex Vivo Modifies Graft Rejection Through Induction of Tolerogenic CD4+CD25+ Cells in the Recipient